Core Viewpoint - The article highlights the illegal sale of banned drugs through e-commerce platforms, emphasizing the need for regulatory oversight to ensure public safety in medication use [1][2] Group 1: Regulatory Actions - The Beijing Railway Transportation Procuratorate identified illegal activities on the e-commerce platform "Bianmin Zhaoyao," where clinics were selling banned drugs without proper medical assessments [1] - Following media exposure in April 2024, the procuratorate initiated an investigation in October, utilizing big data legal supervision models to gather evidence [2] - A public hearing clarified the legal relationship between clinics and users as "sales" rather than "medical treatment," necessitating oversight from market supervision authorities [2] Group 2: Enforcement and Compliance - Joint inspections by market supervision and health departments led to significant actions, including the inspection of 161 medical institutions and online drug sales companies, with 21 drug-related cases being addressed [2] - The procuratorate facilitated the signing of a memorandum to enhance collaboration between administrative agencies for better enforcement against the illegal sale of banned drugs [2] - Measures were implemented to improve the vetting of merchants on e-commerce platforms and to increase transaction risk warnings to prevent illegal activities [2]

Core Viewpoint - The article highlights the illegal sale of banned drugs through e-commerce platforms by certain clinics, which poses a risk of drug abuse and undermines public health interests [1][2]. Group 1: Illegal Sales and Regulatory Actions - Some e-commerce platforms provide a service called "convenient drug search," allowing users to order banned drugs without a proper medical consultation, leading to the illegal circulation of these drugs [1][2]. - The Beijing Railway Transportation Procuratorate established a big data legal supervision model to investigate these illegal sales and initiated a case on October 12, 2024 [1][2]. Group 2: Regulatory Collaboration and Recommendations - Following the investigation, the Beijing Railway Transportation Procuratorate issued recommendations to local market supervision departments to enhance oversight of online drug sales [3]. - A public hearing was held, where experts and representatives from relevant departments agreed that the clinics' actions constituted sales rather than medical consultations, necessitating regulation by market supervision authorities [3]. Group 3: Governance and Long-term Solutions - The Beijing Railway Transportation Procuratorate facilitated the signing of a memorandum to strengthen collaboration among administrative agencies for regulating the sale of banned drugs [4]. - The article emphasizes the need for ongoing governance and regulatory mechanisms to address the challenges posed by new online drug sales models, ensuring public safety in medication use [4].